Genscript Biotech (HKG:1548) associate Legend Biotech logged $334 million in net trade sales of its Carvykti drug in the fourth quarter of 2024, according to a Wednesday filing with the Hong Kong Exchange.
Shares closed 3% higher during Thursday's trading.